Varian Medical Systems Stock Price, News & Analysis (NYSE:VAR)

$108.87 0.08 (0.07 %)
(As of 11/24/2017 02:44 AM ET)
Previous Close$108.79
Today's Range$108.18 - $109.21
52-Week Range$76.94 - $110.23
Volume211,351 shs
Average Volume867,636 shs
Market Capitalization$9.99 billion
P/E Ratio28.86
Dividend YieldN/A
Beta0.65

About Varian Medical Systems (NYSE:VAR)

Varian Medical Systems logoVarian Medical Systems, Inc. is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company also has Varian Particle Therapy (VPT) and the operations of the Ginzton Technology Center (GTC). Its VPT business develops, designs, manufactures, sells and services products and systems for delivering proton therapy, another form of external beam radiotherapy using proton beams for the treatment of cancer. Its ProBeam system is capable of delivering intensity modulated proton therapy (IMPT) using pencil beam scanning technology. Its ProBeam Compact is a single room proton therapy product.

Receive VAR News and Ratings via Email

Sign-up to receive the latest news and ratings for VAR and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Advanced Medical Equipment & Technology
Sub-IndustryHealth Care Equipment
SectorHealthcare
SymbolNYSE:VAR
CUSIP92220P10
Phone+1-650-4245834

Debt

Debt-to-Equity Ratio0.18%
Current Ratio1.41%
Quick Ratio1.13%

Price-To-Earnings

Trailing P/E Ratio28.86
Forward P/E Ratio25.56
P/E Growth3.2

Sales & Book Value

Annual Sales$2.67 billion
Price / Sales3.75
Cash Flow$5.67 per share
Price / Cash19.20
Book Value$16.33 per share
Price / Book6.67

Profitability

Trailing EPS$2.76
Net Income$249.60 million
Net Margins8.85%
Return on Equity23.68%
Return on Assets10.74%

Miscellaneous

Employees7,800
Outstanding Shares91,800,000

Frequently Asked Questions for Varian Medical Systems (NYSE:VAR)

What is Varian Medical Systems' stock symbol?

Varian Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "VAR."

How were Varian Medical Systems' earnings last quarter?

Varian Medical Systems, Inc. (NYSE:VAR) released its earnings results on Wednesday, October, 25th. The medical equipment provider reported $1.09 EPS for the quarter, missing analysts' consensus estimates of $1.19 by $0.10. The medical equipment provider had revenue of $739 million for the quarter, compared to the consensus estimate of $741.69 million. Varian Medical Systems had a return on equity of 23.68% and a net margin of 8.85%. Varian Medical Systems's revenue was down 1.1% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.03 EPS. View Varian Medical Systems' Earnings History.

When will Varian Medical Systems make its next earnings announcement?

Varian Medical Systems is scheduled to release their next quarterly earnings announcement on Tuesday, January, 23rd 2018. View Earnings Estimates for Varian Medical Systems.

What guidance has Varian Medical Systems issued on next quarter's earnings?

Varian Medical Systems updated its FY18 earnings guidance on Wednesday, October, 25th. The company provided earnings per share guidance of $4.20-4.32 for the period, compared to the Thomson Reuters consensus estimate of $4.47. The company issued revenue guidance of $2.72-2.77 billion (+2-4% y/y), compared to the consensus revenue estimate of $2.80 billion.

Where is Varian Medical Systems' stock going? Where will Varian Medical Systems' stock price be in 2017?

10 Wall Street analysts have issued twelve-month price targets for Varian Medical Systems' shares. Their predictions range from $81.50 to $121.00. On average, they anticipate Varian Medical Systems' share price to reach $97.83 in the next twelve months. View Analyst Ratings for Varian Medical Systems.

What are Wall Street analysts saying about Varian Medical Systems stock?

Here are some recent quotes from research analysts about Varian Medical Systems stock:

  • 1. According to Zacks Investment Research, "Varian Medical ended the fourth quarter of fiscal 2017 on a dismal note, missing estimates on both the counts. Unfavorable performance by the company’s proton therapy unit primarily led to the lackluster performance. Varian Medical competes with large electronic companies as well as smaller and more specialized radiation therapy equipment manufacturers. Thus, cut-throat competition in the niche space is likely to mar revenues. Intensifying competition is expected to increase R&D expenditures in the growing proton therapy market, which will keep margins under pressure. However, a solid guidance for fiscal 2018 instills confidence in the stock. The successful launches of Halcyon Therapy System and HyperArc Technology are expected to drive sales. The company has outperformed the broader market over the past six months." (10/27/2017)
  • 2. Jefferies Group LLC analysts commented, "We hosted VAR CEO and CFO for a lunch. Key takeaways: 1) VREX spin process was all inclusive; 2) F17 RemainCo outlook calls for HSD EPS growth; 3) RadOnc outlook stable on multiple fronts near and long-term; 3) next-gen linac expected in 2H17; 5) aim is to double Software in 5-years; 6) proton stable postCTCL with glimmers of light in tunnel; and 7) at least $1.0bn in debt capacity for M&A. We are publishing revised stand-alone estimates and PT of $88." (2/8/2017)

Who are some of Varian Medical Systems' key competitors?

Who are Varian Medical Systems' key executives?

Varian Medical Systems' management team includes the folowing people:

  • R. Andrew Eckert, Independent Chairman of the Board (Age 55)
  • Dow R. Wilson, President, Chief Executive Officer (Age 56)
  • Timothy E. Guertin, Vice Chairman of the Board (Age 67)
  • Elisha W. Finney, Chief Financial Officer, Executive Vice President - Finance (Age 55)
  • Gary E. Bischoping Jr., Chief Financial Officer (Age 49)
  • Kolleen T. Kennedy, Executive Vice President and President - Oncology Systems (Age 57)
  • John W. Kuo, Senior Vice President, General Counsel, Corporate Secretary (Age 53)
  • Juarez Juarez Monroeas, Senior Vice President - Human Resources and Chief People Officer
  • Rafael Torres, Senior Vice President - Business Development and Strategy
  • Jose Baselga M.D., Ph.D., Director (Age 56)

Who owns Varian Medical Systems stock?

Varian Medical Systems' stock is owned by a variety of of institutional and retail investors. Top institutional investors include First Eagle Investment Management LLC (5.21%), Janus Henderson Group PLC (3.85%), Alecta Pensionsforsakring Omsesidigt (2.68%), APG Asset Management N.V. (1.82%), Atlanta Capital Management Co. L L C (1.27%) and Bank of New York Mellon Corp (1.24%). Company insiders that own Varian Medical Systems stock include Clarence R Verhoef, Dow R Wilson, Elisha W Finney, John W Kuo, Kolleen T Kennedy, Mark R Laret, R Andrew Eckert, Ruediger Naumann-Etienne, Susan L Bostrom and Timothy E Guertin. View Institutional Ownership Trends for Varian Medical Systems.

Who sold Varian Medical Systems stock? Who is selling Varian Medical Systems stock?

Varian Medical Systems' stock was sold by a variety of institutional investors in the last quarter, including Point72 Asset Management L.P., Alecta Pensionsforsakring Omsesidigt, Janus Henderson Group PLC, Wells Fargo & Company MN, QV Investors Inc., Schwartz Investment Counsel Inc., PGGM Investments and Russell Investments Group Ltd.. Company insiders that have sold Varian Medical Systems company stock in the last year include Dow R Wilson, John W Kuo, Kolleen T Kennedy, Mark R Laret, R Andrew Eckert, Susan L Bostrom and Timothy E Guertin. View Insider Buying and Selling for Varian Medical Systems.

Who bought Varian Medical Systems stock? Who is buying Varian Medical Systems stock?

Varian Medical Systems' stock was bought by a variety of institutional investors in the last quarter, including APG Asset Management N.V., Old Mutual Global Investors UK Ltd., Renaissance Group LLC, Alyeska Investment Group L.P., JPMorgan Chase & Co., Bank of New York Mellon Corp, American Century Companies Inc. and Ameriprise Financial Inc.. View Insider Buying and Selling for Varian Medical Systems.

How do I buy Varian Medical Systems stock?

Shares of Varian Medical Systems can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Varian Medical Systems' stock price today?

One share of Varian Medical Systems stock can currently be purchased for approximately $108.87.

How big of a company is Varian Medical Systems?

Varian Medical Systems has a market capitalization of $9.99 billion and generates $2.67 billion in revenue each year. The medical equipment provider earns $249.60 million in net income (profit) each year or $2.76 on an earnings per share basis. Varian Medical Systems employs 7,800 workers across the globe.

How can I contact Varian Medical Systems?

Varian Medical Systems' mailing address is 3100 Hansen Way, PALO ALTO, CA 94304-1030, United States. The medical equipment provider can be reached via phone at +1-650-4245834 or via email at [email protected]


MarketBeat Community Rating for Varian Medical Systems (VAR)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  347 (Vote Outperform)
Underperform Votes:  311 (Vote Underperform)
Total Votes:  658
MarketBeat's community ratings are surveys of what our community members think about Varian Medical Systems and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Varian Medical Systems (NYSE:VAR)

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 1.862.002.072.08
Ratings Breakdown: 4 Sell Rating(s)
8 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
8 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
7 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
3 Sell Rating(s)
5 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $96.05$93.05$92.14$92.14
Price Target Upside: 9.69% downside12.82% downside5.73% downside3.97% downside

Consensus Price Target History for Varian Medical Systems (NYSE:VAR)

Price Target History for Varian Medical Systems (NYSE:VAR)

Analysts' Ratings History for Varian Medical Systems (NYSE:VAR)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/30/2017Citigroup Inc.Boost Price TargetNeutral$119.00 -> $121.00N/AView Rating Details
10/29/2017BTIG ResearchReiterated RatingHoldN/AView Rating Details
9/1/2017Royal Bank Of CanadaReiterated RatingHold$100.00N/AView Rating Details
8/28/2017Robert W. BairdReiterated RatingHold$99.00LowView Rating Details
5/17/2017AegisReiterated RatingHold$91.00LowView Rating Details
5/16/2017Goldman Sachs Group IncInitiated CoverageNeutral -> Neutral$92.00LowView Rating Details
5/11/2017Jefferies Group LLCReiterated RatingBuyLowView Rating Details
4/27/2017Barrington ResearchDowngradeOutperform -> Market PerformHighView Rating Details
4/24/2017Off Wall StreetInitiated CoverageSellLowView Rating Details
1/26/2017Evercore ISIDowngradeHold -> Sell$81.50N/AView Rating Details
7/28/2016Morgan StanleyBoost Price TargetUnderweight$80.00 -> $86.00N/AView Rating Details
7/28/2016Brean CapitalBoost Price TargetBuy$87.00 -> $90.00N/AView Rating Details
(Data available from 11/25/2015 forward)

Earnings

Earnings History and Estimates Chart for Varian Medical Systems (NYSE:VAR)

Earnings by Quarter for Varian Medical Systems (NYSE:VAR)

Earnings History by Quarter for Varian Medical Systems (NYSE VAR)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/23/2018$1.00N/AView Earnings Details
10/25/2017Q4 2017$1.19$1.09$741.69 million$739.00 millionViewN/AView Earnings Details
7/26/2017Q3 2017$0.95$1.04$663.86 million$662.40 millionViewN/AView Earnings Details
4/26/2017Q2 2017$0.88$0.89$639.26 million$655.00 millionViewN/AView Earnings Details
10/26/2016Q4112$1.34$1.38$880.29 million$912.00 millionViewListenView Earnings Details
7/27/2016Q316$1.17$1.22$779.90 million$789.40 millionViewListenView Earnings Details
4/27/2016Q216$1.08$1.09$769.56 million$758.80 millionViewListenView Earnings Details
1/27/2016Q116$0.94$0.99$748.01 million$757.00 millionViewListenView Earnings Details
10/28/2015Q4$1.10$1.04$813.18 million$817.80 millionViewListenView Earnings Details
7/29/2015Q3$1.10$1.13$810.41 million$784.00 millionViewListenView Earnings Details
4/29/2015Q215$1.00$1.05$799.66 million$759.40 millionViewN/AView Earnings Details
1/28/2015Q115$0.87$0.99$720.83 million$737.90 millionViewN/AView Earnings Details
10/22/2014Q415$1.21$1.02$837.86 million$812.10 millionViewListenView Earnings Details
7/23/2014Q314$1.09$1.08$767.52 million$747.70 millionViewN/AView Earnings Details
4/23/2014Q4112$1.03$1.04$772.84 million$779.00 millionViewN/AView Earnings Details
1/22/2014Q3112$0.90$0.91$718.23 million$712.00 millionViewN/AView Earnings Details
10/23/2013Q3112$1.12$1.08$779.02 million$770.00 millionViewN/AView Earnings Details
7/24/2013Q3 2013$1.01$1.03$749.01 million$726.20 millionViewN/AView Earnings Details
4/24/2013Q2 2013$1.02$1.04$758.02 million$768.40 millionViewN/AView Earnings Details
1/23/2013Q1 2013$0.87$0.86$676.15 million$678.40 millionViewN/AView Earnings Details
10/25/2012$1.03$1.08ViewN/AView Earnings Details
7/25/2012$0.94$0.96ViewN/AView Earnings Details
4/25/2012$0.96$0.96ViewN/AView Earnings Details
1/25/2012$0.75$0.79ViewN/AView Earnings Details
10/27/2011$0.97$0.95ViewN/AView Earnings Details
7/27/2011$0.83$0.83ViewN/AView Earnings Details
4/27/2011$0.85$0.86ViewN/AView Earnings Details
1/26/2011$0.73$0.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Varian Medical Systems (NYSE:VAR)
2017 EPS Consensus Estimate: $4.18
2018 EPS Consensus Estimate: $4.26
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$1.04$1.06$1.05
Q2 20172$0.91$1.08$1.00
Q3 20172$0.94$0.95$0.95
Q4 20172$1.17$1.20$1.19
Q1 20182$0.92$1.00$0.96
Q2 20182$0.94$1.02$0.98
Q3 20182$1.05$1.06$1.06
Q4 20182$1.26$1.26$1.26
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Varian Medical Systems (NYSE:VAR)

No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Varian Medical Systems (NYSE VAR)

Insider Ownership Percentage: 0.91%
Institutional Ownership Percentage: 99.15%
Insider Trades by Quarter for Varian Medical Systems (NYSE:VAR)
Institutional Ownership by Quarter for Varian Medical Systems (NYSE:VAR)

Insider Trades by Quarter for Varian Medical Systems (NYSE VAR)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/13/2017Kolleen T KennedyEVPSell2,021$107.36$216,974.56View SEC Filing  
10/18/2017Kolleen T KennedyEVPSell931$105.00$97,755.00View SEC Filing  
10/12/2017Kolleen T KennedyEVPSell1,088$101.55$110,486.40View SEC Filing  
10/6/2017Dow R WilsonInsiderSell15,059$102.40$1,542,041.60View SEC Filing  
10/6/2017R Andrew EckertDirectorSell5,651$102.39$578,605.89View SEC Filing  
9/13/2017Kolleen T KennedyEVPSell933$107.29$100,101.57View SEC Filing  
9/12/2017Kolleen T KennedyEVPSell1,088$107.33$116,775.04View SEC Filing  
9/7/2017Dow R WilsonInsiderSell15,059$105.41$1,587,369.19View SEC Filing  
8/31/2017Kolleen T KennedyEVPSell931$105.00$97,755.00View SEC Filing  
8/14/2017Kolleen T KennedyEVPSell1,088$97.91$106,526.08View SEC Filing  
8/7/2017Dow R WilsonInsiderSell15,059$96.48$1,452,892.32View SEC Filing  
7/13/2017John W KuoSVPSell1,597$104.43$166,774.71View SEC Filing  
7/13/2017Kolleen T KennedyEVPSell2,021$104.73$211,659.33View SEC Filing  
7/12/2017John W KuoSVPSell863$104.48$90,166.24View SEC Filing  
7/12/2017Kolleen T KennedyEVPSell1,088$104.49$113,685.12View SEC Filing  
7/10/2017Dow R WilsonInsiderSell15,060$103.37$1,556,752.20View SEC Filing  
6/20/2017Kolleen T KennedyEVPSell26,092$105.00$2,739,660.00View SEC Filing  
6/13/2017John W KuoSVPSell734$101.91$74,801.94View SEC Filing  
6/12/2017John W KuoSVPSell863$101.25$87,378.75View SEC Filing  
6/12/2017Kolleen T KennedyEVPSell1,087$101.20$110,004.40View SEC Filing  
6/9/2017Timothy E GuertinDirectorSell16,000$103.22$1,651,520.00View SEC Filing  
6/8/2017Mark R LaretDirectorSell1,428$103.47$147,755.16View SEC Filing  
6/1/2017Kolleen T KennedyEVPSell56,573$99.76$5,643,722.48View SEC Filing  
5/31/2017John W KuoSVPSell19,819$99.67$1,975,359.73View SEC Filing  
5/12/2017John W KuoSVPSell862$96.39$83,088.18View SEC Filing  
5/2/2017Susan L BostromDirectorSell3,589$91.08$326,886.12View SEC Filing  
4/12/2017John W KuoSVPSell864$89.74$77,535.36View SEC Filing  
3/17/2017John W KuoSVPSell3,876$91.75$355,623.00View SEC Filing  
3/13/2017John W KuoSVPSell862$87.89$75,761.18View SEC Filing  
3/1/2017John W KuoSVPSell10,353$84.81$878,037.93View SEC Filing  
1/5/2017Dow R WilsonInsiderSell13,334$88.74$1,183,259.16View SEC Filing  
12/8/2016John W KuoSVPSell1,267$90.33$114,448.11View SEC Filing  
12/5/2016Dow R WilsonInsiderSell10,000$90.03$900,300.00View SEC Filing  
11/7/2016Dow R WilsonInsiderSell10,000$90.59$905,900.00View SEC Filing  
10/31/2016Timothy E GuertinDirectorSell4,000$90.32$361,280.00View SEC Filing  
10/20/2016John W KuoSVPSell21,266$103.70$2,205,284.20View SEC Filing  
10/5/2016Dow R WilsonInsiderSell10,000$99.44$994,400.00View SEC Filing  
10/3/2016Elisha W FinneyCFOSell4,668$98.87$461,525.16View SEC Filing  
9/15/2016John W KuoSVPSell4,073$95.47$388,849.31View SEC Filing  
9/7/2016Elisha W FinneyCFOSell9,000$96.95$872,550.00View SEC Filing  
9/6/2016Dow R WilsonInsiderSell10,000$96.08$960,800.00View SEC Filing  
9/1/2016Elisha W FinneyCFOSell2,000$95.82$191,640.00View SEC Filing  
8/5/2016Dow R WilsonInsiderSell10,000$95.14$951,400.00View SEC Filing  
8/1/2016Clarence R VerhoefSVPSell9,483$94.88$899,747.04View SEC Filing  
8/1/2016Elisha W FinneyCFOSell25,334$94.90$2,404,196.60View SEC Filing  
8/1/2016Timothy E. GuertinDirectorSell4,000$94.88$379,520.00View SEC Filing  
7/5/2016Dow R WilsonCEOSell10,000$82.08$820,800.00View SEC Filing  
6/27/2016Dow R WilsonCEOSell10,000$78.27$782,700.00View SEC Filing  
6/8/2016Ruediger Naumann-EtienneDirectorSell1,000$84.83$84,830.00View SEC Filing  
6/3/2016Mark R LaretDirectorSell1,545$83.48$128,976.60View SEC Filing  
5/2/2016Timothy E. GuertinDirectorSell4,000$81.55$326,200.00View SEC Filing  
4/20/2016Elisha W FinneyCFOSell4,000$85.95$343,800.00View SEC Filing  
4/18/2016Clarence R VerhoefSVPSell2,500$85.00$212,500.00View SEC Filing  
3/23/2016Dow R WilsonCEOSell45,650$78.86$3,599,959.00View SEC Filing  
3/10/2016Ruediger Naumann-EtienneDirectorSell428$77.99$33,379.72View SEC Filing  
3/7/2016Timothy E. GuertinDirectorSell4,000$79.47$317,880.00View SEC Filing  
2/17/2016Elisha W. FinneyCFOSell2,454$78.59$192,859.86View SEC Filing  
12/7/2015Dow R. WilsonCEOSell9,000$80.00$720,000.00View SEC Filing  
12/2/2015R Andrew EckertDirectorSell3,000$81.67$245,010.00View SEC Filing  
11/24/2015Elisha W. FinneyCFOSell2,334$80.90$188,820.60View SEC Filing  
11/6/2015Dow R. WilsonCEOSell18,000$80.26$1,444,680.00View SEC Filing  
9/8/2015Dow R. WilsonCEOSell9,000$80.05$720,450.00View SEC Filing  
7/6/2015Dow R WilsonCEOSell9,000$85.80$772,200.00View SEC Filing  
7/2/2015Elisha W FinneyCFOSell2,000$85.95$171,900.00View SEC Filing  
7/1/2015Timothy E GuertinDirectorSell25,000$84.20$2,105,000.00View SEC Filing  
6/5/2015Dow R WilsonCEOSell9,000$86.29$776,610.00View SEC Filing  
6/1/2015Elisha W FinneyCFOSell2,000$85.99$171,980.00View SEC Filing  
6/1/2015Timothy E GuertinDirectorSell25,000$86.08$2,152,000.00View SEC Filing  
5/6/2015Dow R WilsonCEOSell9,000$86.64$779,760.00View SEC Filing  
4/17/2015Dow R WilsonCEOSell18,760$93.63$1,756,498.80View SEC Filing  
4/1/2015Elisha W FinneyCFOSell5,000$92.76$463,800.00View SEC Filing  
4/1/2015Timothy E GuertinDirectorSell25,000$92.76$2,319,000.00View SEC Filing  
3/20/2015Dow R WilsonCEOSell18,759$94.44$1,771,599.96View SEC Filing  
3/16/2015Kolleen T KennedyEVPSell1,972$95.00$187,340.00View SEC Filing  
3/6/2015Timothy E GuertinDirectorSell4,000$93.50$374,000.00View SEC Filing  
3/2/2015Elisha W FinneyCFOSell5,000$93.44$467,200.00View SEC Filing  
3/2/2015Timothy E GuertinDirectorSell50,000$93.48$4,674,000.00View SEC Filing  
2/23/2015Elisha W FinneyCFOSell1,326$92.97$123,278.22View SEC Filing  
2/10/2015Mark R LaretDirectorSell10,000$92.32$923,200.00View SEC Filing  
2/3/2015Venkatraman ThyagarajanDirectorSell10,000$92.71$927,100.00View SEC Filing  
2/2/2015Dow R WilsonCEOSell60,000$91.78$5,506,800.00View SEC Filing  
2/2/2015Elisha W FinneyCFOSell6,667$91.79$611,963.93View SEC Filing  
2/2/2015John W KuoSVPSell3,490$92.04$321,219.60View SEC Filing  
2/2/2015Ruediger Naumann-EtienneDirectorSell10,000$91.87$918,700.00View SEC Filing  
1/5/2015Timothy E GuertinDirectorSell50,000$86.27$4,313,500.00View SEC Filing  
1/2/2015Elisha W FinneyCFOSell15,000$87.05$1,305,750.00View SEC Filing  
12/11/2014Timothy E GuertinDirectorSell105,000$86.67$9,100,350.00View SEC Filing  
12/1/2014Elisha W FinneyCFOSell21,000$88.72$1,863,120.00View SEC Filing  
11/24/2014Elisha W FinneyCFOSell2,930$88.24$258,543.20View SEC Filing  
11/17/2014Elisha W FinneyCFOSell1,837$87.71$161,123.27View SEC Filing  
11/11/2014Kolleen T KennedySVPSell1,242$85.79$106,551.18View SEC Filing  
11/10/2014Ruediger Naumann-EtienneDirectorSell5,000$85.31$426,550.00View SEC Filing  
11/3/2014Elisha W FinneyCFOSell25,000$83.82$2,095,500.00View SEC Filing  
11/3/2014Timothy E GuertinDirectorSell80,000$83.72$6,697,600.00View SEC Filing  
10/29/2014Elisha W FinneyCFOSell10,000$83.95$839,500.00View SEC Filing  
10/27/2014Kolleen T KennedySVPSell1,240$81.00$100,440.00View SEC Filing  
10/1/2014Elisha W FinneyCFOSell15,000$79.98$1,199,700.00View SEC Filing  
9/11/2014John W KuoSVPSell605$85.82$51,921.10View SEC Filing  
9/2/2014Elisha W FinneyCFOSell20,000$85.18$1,703,600.00View SEC Filing  
8/20/2014Venkatraman ThyagarajanDirectorSell5,000$84.25$421,250.00View SEC Filing  
8/7/2014Elisha W FinneyCFOSell5,000$83.95$419,750.00View SEC Filing  
8/1/2014Elisha W FinneyCFOSell15,000$81.66$1,224,900.00View SEC Filing  
8/1/2014Timothy E GuertinDirectorSell80,000$81.69$6,535,200.00View SEC Filing  
7/9/2014John W KuoSVPSell582$85.00$49,470.00View SEC Filing  
7/1/2014Elisha W FinneyCFOSell20,000$83.86$1,677,200.00View SEC Filing  
6/23/2014John W KuoSVPSell1,745$85.00$148,325.00View SEC Filing  
6/16/2014Kolleen T KennedySVPSell1,416$82.42$116,706.72View SEC Filing  
6/2/2014Elisha W FinneyCFOSell10,000$82.35$823,500.00View SEC Filing  
5/12/2014Kolleen KennedySVPSell1,417$81.96$116,137.32View SEC Filing  
5/1/2014Elisha FinneyCFOSell10,000$78.99$789,900.00View SEC Filing  
5/1/2014Timothy GuertinDirectorSell80,000$78.98$6,318,400.00View SEC Filing  
4/11/2014Kolleen T KennedySVPSell640$72.15$46,176.00View SEC Filing  
4/1/2014Elisha FinneyCFOSell10,000$83.97$839,700.00View SEC Filing  
3/17/2014Clarence VerhoefSVPSell1,140$84.70$96,558.00View SEC Filing  
3/11/2014Kolleen KennedySVPSell1,417$84.39$119,580.63View SEC Filing  
3/10/2014Timothy GuertinDirectorSell80,000$84.05$6,724,000.00View SEC Filing  
3/3/2014Elisha FinneyCFOSell10,000$83.41$834,100.00View SEC Filing  
2/21/2014Mark LaretDirectorSell1,411$84.06$118,608.66View SEC Filing  
2/11/2014Kolleen KennedySVPSell1,416$80.59$114,115.44View SEC Filing  
2/10/2014R Andrew EckertDirectorSell5,887$80.52$474,021.24View SEC Filing  
2/3/2014Elisha FinneyCFOSell10,000$79.34$793,400.00View SEC Filing  
2/3/2014Timothy GuertinDirectorSell27,000$79.34$2,142,180.00View SEC Filing  
1/31/2014Susan BostromDirectorSell18,900$81.50$1,540,350.00View SEC Filing  
1/2/2014Elisha FinneyCFOSell24,321$77.69$1,889,498.49View SEC Filing  
1/2/2014Richard LevyDirectorSell20,000$77.68$1,553,600.00View SEC Filing  
12/30/2013John KuoSVPSell3,027$77.08$233,321.16View SEC Filing  
12/23/2013Clarence VerhoefSVPSell1,297$76.13$98,740.61View SEC Filing  
12/9/2013Dow WilsonCEOSell95,000$79.09$7,513,550.00View SEC Filing  
12/4/2013Robert KlugeSVPSell12,932$80.00$1,034,560.00View SEC Filing  
12/2/2013Elisha FinneyCFOSell10,000$79.04$790,400.00View SEC Filing  
12/2/2013Richard LevyDirectorSell20,000$79.04$1,580,800.00View SEC Filing  
12/2/2013Robert KlugeSVPSell9,889$79.00$781,231.00View SEC Filing  
11/29/2013Kolleen KennedySVPSell9,307$78.00$725,946.00View SEC Filing  
11/25/2013Kolleen KennedySVPSell2,972$75.49$224,356.28View SEC Filing  
11/22/2013Elisha FinneyCFOSell1,617$74.83$121,000.11View SEC Filing  
11/14/2013Elisha FinneyCFOSell5,000$74.95$374,750.00View SEC Filing  
11/1/2013Elisha W FinneyCFOSell5,000$72.27$361,350.00View SEC Filing  
11/1/2013Richard M LevyDirectorSell20,000$72.27$1,445,400.00View SEC Filing  
10/14/2013Robert KlugeSVPSell13,889$78.00$1,083,342.00View SEC Filing  
10/10/2013Robert KlugeSVPSell13,871$77.00$1,068,067.00View SEC Filing  
9/20/2013Kolleen KennedySVPSell1,247$76.00$94,772.00View SEC Filing  
9/16/2013Elisha FinneyCFOSell16,334$74.95$1,224,233.30View SEC Filing  
9/16/2013Kolleen KennedySVPSell2,562$75.00$192,150.00View SEC Filing  
9/11/2013Elisha W FinneyCFOSell23,666$74.95$1,773,766.70View SEC Filing  
9/3/2013Elisha FinneyCFOSell5,000$70.95$354,750.00View SEC Filing  
9/3/2013Richard LevyDirectorSell20,000$70.95$1,419,000.00View SEC Filing  
8/8/2013Kolleen KennedySVPSell2,400$73.50$176,400.00View SEC Filing  
8/1/2013Elisha W FinneyCFOSell5,000$72.81$364,050.00View SEC Filing  
8/1/2013R Andrew EckertDirectorSell1,375$72.93$100,278.75View SEC Filing  
7/19/2013John W KuoSVPSell1,817$72.00$130,824.00View SEC Filing  
7/17/2013Richard M LevyDirectorSell20,000$70.00$1,400,000.00View SEC Filing  
7/16/2013Elisha W FinneyCFOSell5,000$69.95$349,750.00View SEC Filing  
6/17/2013Elisha W FinneyCFOSell5,000$69.95$349,750.00View SEC Filing  
6/17/2013Richard M LevyDirectorSell20,000$70.00$1,400,000.00View SEC Filing  
6/10/2013Timothy E GuertinDirectorSell27,000$68.81$1,857,870.00View SEC Filing  
5/21/2013Elisha W FinneyCFOSell2,313$69.86$161,586.18View SEC Filing  
5/14/2013Elisha W FinneyCFOSell5,000$69.95$349,750.00View SEC Filing  
5/14/2013John W KuoSVPSell1,112$70.00$77,840.00View SEC Filing  
5/14/2013Richard M LevyDirectorSell20,000$70.00$1,400,000.00View SEC Filing  
2/14/2013John W KuoSVPSell1,111$71.05$78,936.55View SEC Filing  
9/4/2012Kolleen T KennedySVPSell1,900$64.00$121,600.00View SEC Filing  
8/20/2012Elisha W FinneyCFOSell4,000$59.95$239,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Varian Medical Systems (NYSE VAR)

Source:
DateHeadline
Head-To-Head Analysis: Varian Medical Systems (VAR) and Its CompetitorsHead-To-Head Analysis: Varian Medical Systems (VAR) and Its Competitors
www.americanbankingnews.com - November 24 at 9:34 AM
Head-To-Head Contrast: Varian Medical Systems (VAR) & Alliance HealthCare Services (AIQ)Head-To-Head Contrast: Varian Medical Systems (VAR) & Alliance HealthCare Services (AIQ)
www.americanbankingnews.com - November 23 at 9:30 AM
Varian to Open Facility in Brazil, Global Growth in Focus - NasdaqVarian to Open Facility in Brazil, Global Growth in Focus - Nasdaq
www.nasdaq.com - November 22 at 3:59 PM
Varian to Open Facility in Brazil, Global Growth in FocusVarian to Open Facility in Brazil, Global Growth in Focus
finance.yahoo.com - November 22 at 3:59 PM
Varian Medical Systems, Inc. (VAR) Given Average Rating of "Hold" by AnalystsVarian Medical Systems, Inc. (VAR) Given Average Rating of "Hold" by Analysts
www.americanbankingnews.com - November 21 at 1:44 AM
Varians Halcyon Receives Shonin Approval, Grows in Oncology ... - NasdaqVarian's Halcyon Receives Shonin Approval, Grows in Oncology ... - Nasdaq
www.nasdaq.com - November 21 at 12:38 AM
Varian Announces Opening of New Facility in BrazilVarian Announces Opening of New Facility in Brazil
finance.yahoo.com - November 21 at 12:38 AM
Varian's Halcyon Receives Shonin Approval, Grows in OncologyVarian's Halcyon Receives Shonin Approval, Grows in Oncology
finance.yahoo.com - November 20 at 11:59 AM
Varian's Halcyon Receives Shonin Approval, Grows in OncologyVarian's Halcyon Receives Shonin Approval, Grows in Oncology
finance.yahoo.com - November 20 at 11:59 AM
Earnings Review and Free Research Report: Varian’s Adjusted EPS Increased 5.8%Earnings Review and Free Research Report: Varian’s Adjusted EPS Increased 5.8%
finance.yahoo.com - November 18 at 9:59 AM
Varian Halcyon Treatment System Receives Shonin ApprovalVarian Halcyon Treatment System Receives Shonin Approval
finance.yahoo.com - November 18 at 9:59 AM
DNAmito Inc. to Integrate Genomics-Based Personalized Analysis With Varians Oncology Care Management Software ... - PR Newswire (press release)DNAmito Inc. to Integrate Genomics-Based Personalized Analysis With Varian's Oncology Care Management Software ... - PR Newswire (press release)
www.prnewswire.com - November 16 at 5:08 AM
Varian to Showcase Technologies for Enhancing Oncology Care Coordination at AONN+ ConferenceVarian to Showcase Technologies for Enhancing Oncology Care Coordination at AONN+ Conference
finance.yahoo.com - November 16 at 5:08 AM
DNAmito Inc. to Integrate Genomics-Based Personalized Analysis With Varians Oncology Care Management Software Platform to Optimize Physicians Decisions Regarding Radiation Treatment for CancerDNAmito Inc. to Integrate Genomics-Based Personalized Analysis With Varian's Oncology Care Management Software Platform to Optimize Physician's Decisions Regarding Radiation Treatment for Cancer
finance.yahoo.com - November 16 at 5:08 AM
Contrasting Varian Medical Systems (VAR) & The CompetitionContrasting Varian Medical Systems (VAR) & The Competition
www.americanbankingnews.com - November 15 at 7:31 PM
Varian Medical Systems, Inc. (VAR) EVP Kolleen T. Kennedy Sells 2,021 SharesVarian Medical Systems, Inc. (VAR) EVP Kolleen T. Kennedy Sells 2,021 Shares
www.americanbankingnews.com - November 14 at 8:27 PM
Medical Equipment Stock Performance Review -- Senseonics, Xtant Medical ...Medical Equipment Stock Performance Review -- Senseonics, Xtant Medical ...
www.prnewswire.com - November 12 at 1:03 PM
Varian Medical Systems, Inc. (VAR) Expected to Announce Quarterly Sales of $639.47 MillionVarian Medical Systems, Inc. (VAR) Expected to Announce Quarterly Sales of $639.47 Million
www.americanbankingnews.com - November 12 at 6:56 AM
 Analysts Expect Varian Medical Systems, Inc. (VAR) Will Post Earnings of $0.99 Per Share Analysts Expect Varian Medical Systems, Inc. (VAR) Will Post Earnings of $0.99 Per Share
www.americanbankingnews.com - November 10 at 2:11 PM
Varian Medical Systems (VAR) versus Its Competitors Head-To-Head ComparisonVarian Medical Systems (VAR) versus Its Competitors Head-To-Head Comparison
www.americanbankingnews.com - November 10 at 10:06 AM
Comparing Varian Medical Systems (VAR) & Presbia PLC (LENS)Comparing Varian Medical Systems (VAR) & Presbia PLC (LENS)
www.americanbankingnews.com - November 9 at 11:06 PM
Comparing Varian Medical Systems (VAR) & The CompetitionComparing Varian Medical Systems (VAR) & The Competition
www.americanbankingnews.com - November 8 at 2:08 PM
Earnings Momentum Make Varian Medical Systems (VAR) a Buy - Investorplace.comEarnings Momentum Make Varian Medical Systems (VAR) a Buy - Investorplace.com
investorplace.com - November 8 at 4:10 AM
Earnings Momentum Make Varian Medical Systems (VAR) a BuyEarnings Momentum Make Varian Medical Systems (VAR) a Buy
investorplace.com - November 7 at 6:19 PM
Varian Medical Systems Earns Relative Strength Rating Upgrade; Hits Key BenchmarkVarian Medical Systems Earns Relative Strength Rating Upgrade; Hits Key Benchmark
finance.yahoo.com - November 7 at 6:05 PM
Treatments Commence at Two Algerian Hospitals Equipped with Modern Varian Radiotherapy SystemsTreatments Commence at Two Algerian Hospitals Equipped with Modern Varian Radiotherapy Systems
finance.yahoo.com - November 6 at 8:49 AM
Varian Selected in Multi-Year Project to Replace Radiotherapy Treatment Equipment at Copenhagens Rigshospitalet and Herlev HospitalVarian Selected in Multi-Year Project to Replace Radiotherapy Treatment Equipment at Copenhagen's Rigshospitalet and Herlev Hospital
finance.yahoo.com - November 3 at 10:08 AM
Cutera, Inc. Names Elisha Wade Finney to its Board of Directors - GlobeNewswire (press release)Cutera, Inc. Names Elisha Wade Finney to its Board of Directors - GlobeNewswire (press release)
globenewswire.com - November 1 at 10:19 AM
Global Availability of Varian Halcyon Treatments Expands with First Cancer Patient Treated in AustraliaGlobal Availability of Varian Halcyon Treatments Expands with First Cancer Patient Treated in Australia
finance.yahoo.com - November 1 at 10:18 AM
Varian Names New Chief People Officer, SVP HRVarian Names New Chief People Officer, SVP HR
finance.yahoo.com - October 31 at 11:41 AM
Varian Medical Systems, Inc. breached its 50 day moving average in a Bearish Manner : VAR-US : October 31, 2017Varian Medical Systems, Inc. breached its 50 day moving average in a Bearish Manner : VAR-US : October 31, 2017
finance.yahoo.com - October 31 at 11:41 AM
Varian Medical Systems, Inc. (VAR) Price Target Increased to $121.00 by Analysts at Citigroup Inc.Varian Medical Systems, Inc. (VAR) Price Target Increased to $121.00 by Analysts at Citigroup Inc.
www.americanbankingnews.com - October 30 at 3:28 PM
Barrington Research Weighs in on Varian Medical Systems, Inc.s Q1 2018 Earnings (VAR)Barrington Research Weighs in on Varian Medical Systems, Inc.'s Q1 2018 Earnings (VAR)
www.americanbankingnews.com - October 30 at 7:56 AM
Research Analysts Issue Forecasts for Varian Medical Systems, Inc.s Q1 2018 Earnings (VAR)Research Analysts Issue Forecasts for Varian Medical Systems, Inc.'s Q1 2018 Earnings (VAR)
www.americanbankingnews.com - October 30 at 7:56 AM
Varian Medical Systems, Inc. (VAR) Rating Lowered to Sell at Zacks Investment ResearchVarian Medical Systems, Inc. (VAR) Rating Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - October 28 at 7:34 PM
Analysts Offer Predictions for Varian Medical Systems, Inc.s Q2 2018 Earnings (VAR)Analysts Offer Predictions for Varian Medical Systems, Inc.'s Q2 2018 Earnings (VAR)
www.americanbankingnews.com - October 27 at 4:06 PM
Q2 2018 EPS Estimates for Varian Medical Systems, Inc. Reduced by Analyst (VAR)Q2 2018 EPS Estimates for Varian Medical Systems, Inc. Reduced by Analyst (VAR)
www.americanbankingnews.com - October 27 at 4:06 PM
Varian Medical (VAR) Misses on Q4 Earnings, Issues FY18 View - NasdaqVarian Medical (VAR) Misses on Q4 Earnings, Issues FY18 View - Nasdaq
www.nasdaq.com - October 27 at 7:31 AM
Varian Medical Systems, Inc. (VAR) Receives Average Rating of "Hold" from AnalystsVarian Medical Systems, Inc. (VAR) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - October 27 at 1:30 AM
Varian Medical tumbles more than 6% after disappointing earnings, forecast - MarketWatchVarian Medical tumbles more than 6% after disappointing earnings, forecast - MarketWatch
www.marketwatch.com - October 26 at 12:03 PM
Varian Medical Systems (VAR) Dow Wilson on Q4 2017 Results - Earnings Call Transcript - Seeking AlphaVarian Medical Systems (VAR) Dow Wilson on Q4 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - October 26 at 12:03 PM
Edited Transcript of VAR earnings conference call or presentation 25-Oct-17 9:00pm GMTEdited Transcript of VAR earnings conference call or presentation 25-Oct-17 9:00pm GMT
finance.yahoo.com - October 26 at 12:03 PM
Varian Medical Systems, Inc. (VAR) Posts  Earnings Results, Misses Expectations By $0.10 EPSVarian Medical Systems, Inc. (VAR) Posts Earnings Results, Misses Expectations By $0.10 EPS
www.americanbankingnews.com - October 25 at 10:50 PM
Varian Medical tumbles more than 6% after disappointing earnings, forecastVarian Medical tumbles more than 6% after disappointing earnings, forecast
finance.yahoo.com - October 25 at 8:56 PM
Varian Medical Systems, Inc. (VAR) Issues FY18 Earnings GuidanceVarian Medical Systems, Inc. (VAR) Issues FY18 Earnings Guidance
www.americanbankingnews.com - October 25 at 6:28 PM
MedTech Stocks (BAX, VAR, TMO, LH) Earnings Preview: What You Should KnowMedTech Stocks (BAX, VAR, TMO, LH) Earnings Preview: What You Should Know
finance.yahoo.com - October 24 at 4:06 PM
Global Radiotherapy Market to 2024 - Varian Medical Systems ... - Business Wire (press release)Global Radiotherapy Market to 2024 - Varian Medical Systems ... - Business Wire (press release)
www.businesswire.com - October 24 at 11:56 AM
First Patients in US Treated with Varian HyperArc High Definition RadiotherapyFirst Patients in US Treated with Varian HyperArc High Definition Radiotherapy
finance.yahoo.com - October 24 at 11:56 AM
Mass confusion over Obamacare plansMass confusion over Obamacare plans
finance.yahoo.com - October 23 at 8:46 AM
Eye Cancer Patient Treated Using Varians new HyperArc High Definition Radiotherapy TechnologyEye Cancer Patient Treated Using Varian's new HyperArc High Definition Radiotherapy Technology
finance.yahoo.com - October 23 at 8:46 AM

Social Media

Financials

Chart

Varian Medical Systems (NYSE VAR) Chart for Saturday, November, 25, 2017
Loading chart…

This page was last updated on 11/25/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.